SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-038198
Filing Date
2022-10-24
Accepted
2022-10-24 10:00:19
Documents
12
Period of Report
2022-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K brhc10043182_8k.htm   iXBRL 8-K 42991
  Complete submission text file 0001140361-22-038198.txt   181075

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20221020.xsd EX-101.SCH 3875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20221020_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20221020_pre.xml EX-101.PRE 16051
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10043182_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 221324989
SIC: 2834 Pharmaceutical Preparations